Type: Deck Idea
Format (legal 👍) legLegacy
Approx. Value:
$139.39
Buy

0 Likes 0 Comments
Avg. CMC 1.59
Card Color Breakdown
Card Type Breakdown

Please consider subscribing to a Deckbox Premium Account, which provides many useful collecting, trading and deckbuilding features and removes ads! View More Details
Please consider subscribing to a Deckbox Premium Account, which provides many useful collecting, trading and deckbuilding features and removes ads! View More Details
Main Deck - 60 cards, 21 distinct
Columns
Name  Edition $ Type Cost
Rarity Color
Creature (25)
4 Ambush Viper
$0.07 Creature - Snake
2 Charging Badger
$0.07 Creature - Badger
2 Elvish Herder
$0.38 Creature - Elf
3 Giant Scorpion
$0.03 Creature - Scorpion
1 Hornet Nest
$0.92 Creature - Insect
2 Thrill-Kill Assassin
$0.21 Creature - Human Assassin
3 Turntimber Basilisk
$0.32 Creature - Basilisk
4 Typhoid Rats
$0.13 Creature - Rat
3 Vampire Nighthawk
$0.22 Creature - Vampire Shaman
1 Wasteland Viper
$0.41 Creature - Snake
Instant (10)
1 Berserk
$92.70 Instant
3 Prey's Vengeance
$0.05 Instant
3 Unnatural Predation
$0.08 Instant
3 Virulent Swipe
$0.10 Instant
Sorcery (2)
2 Deadly Allure
$0.09 Sorcery
Artifact (2)
2 Elixir of Immortality
$0.41 Artifact
Enchantment (2)
2 Rancor
$1.10 Enchantment - Aura
Land (19)
8 Forest
$0.09 Basic Land - Forest
2 Overgrown Tomb
$11.57 Land - Swamp Forest
8 Swamp
$1.59 Basic Land - Swamp
1 Woodland Cemetery
$1.06 Land
Sideboard - 0 cards, 0 distinct
No cards here. :(

Notes
 
I have brought trample and deathtouch together before with decks such as One And Done and Kali (the latter having 21 cards in common with this deck). The goal is to pair deathtouch and trampling with speed and from both directions. Spells can grant either, and creatures tend to have one or the other. Thus, they can be working in a variety of ways. The two copies of Elixir of Immortality make it possible to keep going, even after sustaining heavy casualties. The 25(!)/6/10 curve packs room for a 41st card by dint of averaging only 1.63.
Comments
    No comments yet.